The Relationship between Serum Leukotriene B4 and High-Sensitivity C-Reactive Protein Expression Levels and Adverse Reactions in Patients with Colon Cancer During Perioperative Blood Transfusion

To explore the predictive value of serum high-sensitivity C-reactive protein and leukotriene B4 in perioperative blood transfusion patients with colon cancer adverse reactions. 168 undergoing surgery a hospital from March 2018 to 2020 were selected as research objects checked levels venous all patients. There 73 cases group (experimental group) 95 non-transfusion reaction (control group). The two groups compared. Based on analysis basic data patients, are independent risk factors for reactions experimental higher than those normal there differences, both statistically significant (p<0.05); receiver operating characteristic curve results showed that area under alone combination predict 0.733, 0.819 0.877, respectively. combined factor diagnosis was greater single diagnosis; protein≥14.64 mg/l B4≥18.86 pg/l transfusion. Elevated during High-sensitivity suggest may occur. can increase incidence